Notably, aberrant KRT19 expression has been implicated in tumor proliferation, metastasis and survival in hepatocellular carcinoma [20], breast cancer [21, 22], colorectal cancer [23], and is closely associated with the prognosis of various tumors [44]. This evidence concerns the gene KRT19 and breast carcinoma.